Cognitive functioning in individuals at ultra-high risk for psychosis, first-degree relatives of patients with psychosis and patients with first-episode schizophrenia

Schizophrenia Research

Volumn 174, Issue 1-3, 2016, Pages 71-76

  Hou, Cai Lan ^a   Xiang, Yu Tao ^b   Wang, Zhong Lei ^c   Everall, Ian ^d   Tang, Yi ^a   Yang, Chengjia ^a   Xu, Ming Zhi ^a   Correll, Christoph U ^e   Jia, Fu Jun ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b University of Macau   (Macao)

^c SHENZHEN KANGNING HOSPITAL   (China)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e ZUCKER HILLSIDE HOSPITAL   (United States)

Author keywords

Cognitive functioning; Schizophrenia; Ultra high risk for psychosis

Indexed keywords

ARTICLE; ATTENTION; CHINA; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DIGIT SYMBOL SUBSTITUTION TEST; EDUCATION; EMPLOYMENT STATUS; EXECUTIVE FUNCTION; FAMILY HISTORY; FEMALE; FIRST DEGREE RELATIVE; FIRST EPISODE SCHIZOPHRENIA; GENETIC RISK; HIGH RISK PATIENT; HOPKINS VERBAL LEARNING TEST; HUMAN; INTERVIEW; MALE; MARRIED PERSON; MENTAL DISEASE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PRODROMAL SYMPTOM; PSYCHOSIS; SCHIZOPHRENIA; STROOP TEST; STRUCTURED INTERVIEW; TRAIL MAKING TEST; ULTRA HIGH RISK PATIENT; VERBAL MEMORY; WORKING MEMORY; ADULT; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; FAMILY; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL INTERVIEW; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; RISK; SHORT TERM MEMORY; YOUNG ADULT;

ADULT; ATTENTION; COGNITION; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; FAMILY; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MEMORY, SHORT-TERM; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISK; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 84967184768     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2016.04.034     Document Type: Article

References (51)

1. Agnew-Blais J., Seidman L.J. Neurocognition in youth and young adults under age 30 at familial risk for schizophrenia: a quantitative and qualitative review. Cogn. Neuropsychiatry 2013, 18:44-82.
2. Besnier N., Richard F., Zendjidjian X., Kaladjian A., Mazzola-Pomietto P., Adida M., Azorin J.M. Stroop and emotional Stroop interference in unaffected relatives of patients with schizophrenic and bipolar disorders: distinct markers of vulnerability?. World J. Biol. Psychiatry 2009, 10:809-818.
3. Bora E., Lin A., Wood S.J., Yung A.R., McGorry P.D., Pantelis C. Cognitive deficits in youth with familial and clinical high risk to psychosis: a systematic review and meta-analysis. Acta Psychiatr. Scand. 2014, 130:1-15.
4. Bora E., Yucel M., Pantelis C. Cognitive impairment in schizophrenia and affective psychoses: implications for DSM-V criteria and beyond. Schizophr. Bull. 2010, 36:36-42.
5. Breton F., Plante A., Legauffre C., Morel N., Ades J., Gorwood P., Ramoz N., Dubertret C. The executive control of attention differentiates patients with schizophrenia, their first-degree relatives and healthy controls. Neuropsychologia 2011, 49:203-208.
6. Cannon T.D., Cadenhead K., Cornblatt B., Woods S.W., Addington J., Walker E., Seidman L.J., Perkins D., Tsuang M., McGlashan T., et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch. Gen. Psychiatry 2008, 65:28-37.
7. Chung Y.S., Kang D.H., Shin N.Y., Yoo S.Y., Kwon J.S. Deficit of theory of mind in individuals at ultra-high-risk for schizophrenia. Schizophr. Res. 2008, 99:111-118.
8. Correll C.U., Hauser M., Auther A.M., Cornblatt B.A. Research in people with psychosis risk syndrome: a review of the current evidence and future directions. J. Child Psychol. Psychiatry 2010, 51:390-431.
9. Corrigan J.D., Hinkeldey N.S. Relationships between parts A and B of the Trail Making Test. J. Clin. Psychol. 1987, 43:402-409.
10. De Herdt A., Wampers M., Vancampfort D., De Hert M., Vanhees L., Demunter H., Van Bouwel L., Brunner E., Probst M. Neurocognition in clinical high risk young adults who did or did not convert to a first schizophrenic psychosis: a meta-analysis. Schizophr. Res. 2013, 149:48-55.
11. de la Serna E., Baeza I., Andres S., Puig O., Sanchez-Guistau V., Romero S., Bernardo M., Moreno D., Noguera A., Castro-Fornieles J. Comparison between young siblings and offspring of subjects with schizophrenia: clinical and neuropsychological characteristics. Schizophr. Res. 2011, 131:35-42.
12. Dickson H., Cullen A.E., Reichenberg A., Hodgins S., Campbell D.D., Morris R.G., Laurens K.R. Cognitive impairment among children at-risk for schizophrenia. J. Psychiatr. Res. 2014, 50:92-99.
13. Dickson H., Laurens K.R., Cullen A.E., Hodgins S. Meta-analyses of cognitive and motor function in youth aged 16 years and younger who subsequently develop schizophrenia. Psychol. Med. 2012, 42:743-755.
14. Eastvold A.D., Heaton R.K., Cadenhead K.S. Neurocognitive deficits in the (putative) prodrome and first episode of psychosis. Schizophr. Res. 2007, 93:266-277.
15. Frank R.M., Byrne G.J. The clinical utility of the Hopkins Verbal Learning Test as a screening test for mild dementia. Int. J. Geriatr. Psychiatry 2000, 15:317-324.
16. Fusar-Poli P., Bonoldi I., Yung A.R., Borgwardt S., Kempton M.J., Valmaggia L., Barale F., Caverzasi E., McGuire P. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch. Gen. Psychiatry 2012, 69:220-229.
17. Fusar-Poli P., Deste G., Smieskova R., Barlati S., Yung A.R., Howes O., Stieglitz R.D., Vita A., McGuire P., Borgwardt S. Cognitive functioning in prodromal psychosis: a meta-analysis. Arch. Gen. Psychiatry 2012, 69:562-571.
18. Giakoumaki S.G. Cognitive and prepulse inhibition deficits in psychometrically high schizotypal subjects in the general population: relevance to schizophrenia research. J. Int. Neuropsychol. Soc. 2012, 18:643-656.
19. Giuliano A.J., Li H., Mesholam-Gately R.I., Sorenson S.M., Woodberry K.A., Seidman L.J. Neurocognition in the psychosis risk syndrome: a quantitative and qualitative review. Curr. Pharm. Des. 2012, 18:399-415.
20. Hawkins K.A., Addington J., Keefe R.S., Christensen B., Perkins D.O., Zipurksy R., Woods S.W., Miller T.J., Marquez E., Breier A., et al. Neuropsychological status of subjects at high risk for a first episode of psychosis. Schizophr. Res. 2004, 67:115-122.
21. He Y.L., Zhang M.Y. The positive and negative syndrome scale (PANSS) and its application (in Chinese). J. Clin. Psychiatry 1997, 7:353-355.
22. Homack S., Riccio C.A. A meta-analysis of the sensitivity and specificity of the Stroop Color and Word Test with children. Arch. Clin. Neuropsychol. 2004, 19:725-743.
23. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13:261-276.
24. Keefe R.S., Perkins D.O., Gu H., Zipursky R.B., Christensen B.K., Lieberman J.A. A longitudinal study of neurocognitive function in individuals at-risk for psychosis. Schizophr. Res. 2006, 88:26-35.
25. Kelleher I., Clarke M.C., Rawdon C., Murphy J., Cannon M. Neurocognition in the extended psychosis phenotype: performance of a community sample of adolescents with psychotic symptoms on the MATRICS neurocognitive battery. Schizophr. Bull. 2013, 39:1018-1026.
26. Kelleher I., Murtagh A., Clarke M.C., Murphy J., Rawdon C., Cannon M. Neurocognitive performance of a community-based sample of young people at putative ultra high risk for psychosis: support for the processing speed hypothesis. Cogn. Neuropsychiatry 2013, 18:9-25.
27. Lencz T., Smith C.W., McLaughlin D., Auther A., Nakayama E., Hovey L., Cornblatt B.A. Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biol. Psychiatry 2006, 59:863-871.
28. Lesh T.A., Tanase C., Geib B.R., Niendam T.A., Yoon J.H., Minzenberg M.J., Ragland J.D., Solomon M., Carter C.S. A multimodal analysis of antipsychotic effects on brain structure and function in first-episode schizophrenia. JAMA Psychiatry 2015, 72:226-234.
29. Lin A., Yung A.R., Nelson B., Brewer W.J., Riley R., Simmons M., Pantelis C., Wood S.J. Neurocognitive predictors of transition to psychosis: medium- to long-term findings from a sample at ultra-high risk for psychosis. Psychol. Med. 2013, 43:2349-2360.
30. Matheson S.L., Shepherd A.M., Laurens K.R., Carr V.J. A systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia. Schizophr. Res. 2011, 133:133-142.
31. Maziade M., Rouleau N., Merette C., Cellard C., Battaglia M., Marino C., Jomphe V., Gilbert E., Achim A., Bouchard R.H., et al. Verbal and visual memory impairments among young offspring and healthy adult relatives of patients with schizophrenia and bipolar disorder: selective generational patterns indicate different developmental trajectories. Schizophr. Bull. 2011, 37:1218-1228.
32. Mesholam-Gately R.I., Giuliano A.J., Goff K.P., Faraone S.V., Seidman L.J. Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology 2009, 23:315-336.
33. Miller T.J., McGlashan T.H., Rosen J.L., Cadenhead K., Cannon T., Ventura J., McFarlane W., Perkins D.O., Pearlson G.D., Woods S.W. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr. Bull. 2003, 29:703-715.
34. Mukkala S., Ilonen T., Nordstrom T., Miettunen J., Loukkola J., Barnett J.H., Murray G.K., Jaaskelainen E., Maki P., Taanila A., et al. Different vulnerability indicators for psychosis and their neuropsychological characteristics in the Northern Finland 1986 Birth Cohort. J. Clin. Exp. Neuropsychol. 2011, 33:385-394.
35. Murray R.M., Lewis S.W. Is schizophrenia a neurodevelopmental disorder?. Br. Med. J. (Clin. Res. Ed.) 1987, 295:681-682.
36. Myles-Worsley M., Ord L.M., Ngiralmau H., Weaver S., Blailes F., Faraone S.V. The Palau Early Psychosis Study: neurocognitive functioning in high-risk adolescents. Schizophr. Res. 2007, 89:299-307.
37. Nuechterlein K.H., Green M.F., Kern R.S., Baade L.E., Barch D.M., Cohen J.D., Essock S., Fenton W.S., Frese F.J., Gold J.M., et al. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am. J. Psychiatry 2008, 165:203-213.
38. Pukrop R., Klosterkotter J. Neurocognitive indicators of clinical high-risk states for psychosis: a critical review of the evidence. Neurotox. Res. 2010, 18:272-286.
39. Pukrop R., Schultze-Lutter F., Ruhrmann S., Brockhaus-Dumke A., Tendolkar I., Bechdolf A., Matuschek E., Klosterkotter J. Neurocognitive functioning in subjects at risk for a first episode of psychosis compared with first- and multiple-episode schizophrenia. J. Clin. Exp. Neuropsychol. 2006, 28:1388-1407.
40. Reichenberg A., Harvey P.D. Neuropsychological impairments in schizophrenia: integration of performance-based and brain imaging findings. Psychol. Bull. 2007, 133:833-858.
41. Seidman L.J., Giuliano A.J., Meyer E.C., Addington J., Cadenhead K.S., Cannon T.D., McGlashan T.H., Perkins D.O., Tsuang M.T., Walker E.F., et al. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Arch. Gen. Psychiatry 2010, 67:578-588.
42. Seidman L.J., Giuliano A.J., Smith C.W., Stone W.S., Glatt S.J., Meyer E., Faraone S.V., Tsuang M.T., Cornblatt B. Neuropsychological functioning in adolescents and young adults at genetic risk for schizophrenia and affective psychoses: results from the Harvard and Hillside Adolescent High Risk Studies. Schizophr. Bull. 2006, 32:507-524.
43. Shapiro A.M., Benedict R.H., Schretlen D., Brandt J. Construct and concurrent validity of the Hopkins Verbal Learning Test-Revised. Clin. Neuropsychol. 1999, 13:348-358.
44. Snitz B.E., Macdonald A.W., Carter C.S. Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophr. Bull. 2006, 32:179-194.
45. Torniainen M., Suvisaari J., Partonen T., Castaneda A.E., Kuha A., Perala J., Saarni S., Lonnqvist J., Tuulio-Henriksson A. Sex differences in cognition among persons with schizophrenia and healthy first-degree relatives. Psychiatry Res. 2011, 188:7-12.
46. Ucok A., Direk N., Koyuncu A., Keskin-Ergen Y., Yuksel C., Guler J., Karadayi G., Akturan E., Devrim-Ucok M. Cognitive deficits in clinical and familial high risk groups for psychosis are common as in first episode schizophrenia. Schizophr. Res. 2013, 151:265-269.
47. Velthorst E., Nieman D.H., Becker H.E., van de Fliert R., Dingemans P.M., Klaassen R., de Haan L., van Amelsvoort T., Linszen D.H. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis. Schizophr. Res. 2009, 109:60-65.
48. Woodberry K.A., Seidman L.J., Giuliano A.J., Verdi M.B., Cook W.L., McFarlane W.R. Neuropsychological profiles in individuals at clinical high risk for psychosis: relationship to psychosis and intelligence. Schizophr. Res. 2010, 123:188-198.
49. Yung A.R., Nelson B. The ultra-high risk concept-a review. Can. J. Psychiatr. 2013, 58:5-12.
50. Yung A.R., Phillips L.J., Yuen H.P., McGorry P.D. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr. Res. 2004, 67:131-142.
51. Ziermans T., de Wit S., Schothorst P., Sprong M., van Engeland H., Kahn R., Durston S. Neurocognitive and clinical predictors of long-term outcome in adolescents at ultra-high risk for psychosis: a 6-year follow-up. PLoS One 2014, 9:e93994.